Clinical Trial Disclosure

Eisai Co., Ltd. is a global research and development-based pharmaceutical company headquartered in Japan.

This website contains information on recent clinical trials run by Eisai. Included on this site are the trials that were part of dossiers for medicines and indications submitted and approved from 1st January 2014 in the United States (US) and the European Union (EU).

Eisai enhances patient health through transparency in its clinical research and the responsible sharing of clinical trial data in keeping with our human health care (hhc) mission. We define our hhc mission as “giving first thought to patients and their families and to increasing the benefits health care provides.”